Sex-steroid control of the aging somatotropic axis

Endocrinology and Metabolism Clinics of North America

Volumn 34, Issue 4, 2005, Pages 877-893

  Veldhuis, Johannes D ^a   Erickson, Dana ^a   Iranmanesh, Ali ^b,c   Miles, John M ^a   Bowers, Cyril Y ^d  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTRADIOL; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; PRALMORELIN; RECOMBINANT GROWTH HORMONE; RECOMBINANT HORMONE; RECOMBINANT SOMATOMEDIN C; SEX HORMONE;

AGING; ENDOCRINE DISEASE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEXUAL MATURATION;

AGED; AGING; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; PITUITARY GLAND;

EID: 27944439282     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2005.07.006     Document Type: Review

References (94)

1. J.W. Finkelstein, H.P. Roffwarg, and R.M. Boyar Age-related change in the twenty-four-hour spontaneous secretion of growth hormone J Clin Endocrinol Metab 35 1972 665 670
2. Z. Zadik, S.A. Chalew, and R.J. McCarter Jr. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals J Clin Endocrinol Metab 60 1985 513 516
3. K.K.Y. Ho, W.S. Evans, and R.M. Blizzard Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations J Clin Endocrinol Metab 64 1987 51 58
4. A. Iranmanesh, G. Lizarralde, and J.D. Veldhuis Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men J Clin Endocrinol Metab 73 1991 1081 1088
5. A. Iranmanesh, B. Grisso, and J.D. Veldhuis Low basal and persistent pulsatile growth hormone secretions are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay J Clin Endocrinol Metab 78 1994 526 535
6. A. Weltman, J.Y. Weltman, and M.L. Hartman Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender J Clin Endocrinol Metab 78 1994 543 548
7. A. Iranmanesh, S. South, and A.Y. Liem Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men Eur J Endocrinol 139 1998 59 71
8. H.J. Lieman, T.E. Adel, and C. Forst Effects of aging and estradiol supplementation on GH axis dynamics in women J Clin Endocrinol Metab 86 2001 3918 3923
9. E. Arvat, G.P. Ceda, and L. Di Vito Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging Pituitary 1 1998 51 58
10. A. Giustina, and J.D. Veldhuis Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human Endocr Rev 19 1998 717 797
11. C.A. Lissett, and S.M. Shalet The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing Clin Endocrinol (Oxf) 58 2003 238 245
12. E. Arvat, G. Ceda, and J. Ramunni The IGF-I response to very low rhGH doses is preserved in human ageing Clin Endocrinol (Oxf) 49 1998 757 763
13. J.D. Veldhuis, and C.Y. Bowers Sex steroid modulation of growth hormone (GH) secretory control: tripeptidyl ensemble regulation under dual feedback restraint by GH and IGF-I Endocrine 22 2003 25 40
14. A. Juul, T. Scheike, and M. Davidsen Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study Circulation 106 2002 939 944
15. G.A. Laughlin, E. Barrett-Connor, and M.H. Criqui The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study J Clin Endocrinol Metab 89 2004 114 120
16. A.G. Frantz, and M.T. Rabkin Effects of estrogen and sex difference on secretion of human growth hormone J Clin Endocrinol Metab 25 1965 1470 1480
17. E. Wiedemann, E. Schwartz, and A.G. Frantz Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man J Clin Endocrinol Metab 42 1976 942 952
18. M. Rosilio, W.F. Blum, and D.J. Edwards Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH Deficiency, as measured by Questions on Life Satisfaction-Hypopituitarism (QLS-H) J Clin Endocrinol Metab 89 2004 1684 1693
19. J.D. Veldhuis, A.Y. Liem, and S. South Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay J Clin Endocrinol Metab 80 1995 3209 3222
20. H. Pijl, J.G. Langendonk, and J. Burggraaf Altered neuroregulation of GH secretion in viscerally obese premenopausal women J Clin Endocrinol Metab 86 2001 5509 5515
21. N. Shah, W.S. Evans, and J.D. Veldhuis Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion Am J Physiol 276 1999 R1351 R1358
22. A. Gentili, T. Mulligan, and M. Godschalk Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men J Clin Endocrinol Metab 87 2002 825 834
23. J.D. Veldhuis, J.N. Roemmich, and E.J. Richmond Endocrine control of body composition in infancy, childhood and puberty Endocr Rev 26 1 2005 114 146
24. J.D. Veldhuis, W.S. Evans, and C.Y. Bowers Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2 Endocrine 14 2001 45 62
25. A.J. Weissberger, and K.K.Y. Ho Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization J Clin Endocrinol Metab 1407 1993 1412
26. J. Devesa, N. Lois, and V. Arce The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans J Steroid Biochem Mol Biol 40 1991 165 173
27. J.D. Veldhuis, D.L. Metzger, and P.M. Martha Jr. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex steroid hormone replacement J Clin Endocrinol Metab 82 1997 3414 3420
28. D.M. Keenan, F. Roelfsema, and N. Biermasz Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis Am J Physiol 285 2003 R664 R673
29. D. Le Roith, C. Bondy, and S. Yakar The somatomedin hypothesis 2001 Endocr Rev 22 2001 53 74
30. J.C. Achermann, C.G. Brook, and I.C. Robinson Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children Clin Endocrinol (Oxf) 50 1999 301 308
31. C.A. Jaffe, D.K. Turgeon, and K. Lown Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans Am J Physiol Endocrinol Metab 283 2002 E1008 E1015
32. A. Lindahl, J. Isgaard, and L. Carlsson Differential effects of growth hormone and insulin-like growth factor I on colony formation of epiphyseal chondrocytes in suspension culture in rats of different ages Endocrinology 121 1987 1061 1069
33. N. Mauras, K.O. O'Brien, and S. Welch Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism J Clin Endocrinol Metab 85 2000 1686 1694
34. G. Johannsson, R. Bjarnason, and M. Bramnert The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender J Clin Endocrinol Metab 81 1996 1575 1581
35. M. Duenas, I. Torres-Aleman, and F. Naftolin Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation Neuroscience 74 1996 531 539
36. R.J. Lichtenwalner, M.E. Forbes, and S.A. Bennett Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis Neuroscience 107 2001 603 613
37. L.S. Farhy, M. Straume, and M.L. Johnson A construct of interactive feedback control of the GH axis in the male Am J Physiol 281 2001 R38 R51
38. L.S. Farhy, M. Straume, and M.L. Johnson Unequal autonegative feedback by GH models the sexual dimorphism in GH secretory dynamics Am J Physiol 282 2002 R753 R764
39. L.S. Farhy, and J.D. Veldhuis Joint pituitary hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion Am J Physiol Regul Integr Comp Physiol 285 2003 R1240 R1249
40. L.S. Farhy, and J.D. Veldhuis Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator Am J Physiol 286 2004 R1030 R1042
41. D.L. Metzger, and J.R. Kerrigan Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence J Clin Endocrinol Metab 79 1994 513 518
42. D.A. Fryburg, A. Weltman, and L.A. Jahn Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men J Clin Endocrinol Metab 82 1997 3710 3719
43. S.S.C. Yen, P. Vela, and J. Rankin Hormonal relationships during the menstrual cycle JAMA 211 1970 1513 1517
44. A.C.S. Faria, L.W. Bekenstein, and R.A. Booth Jr. Pulsatile growth hormone release in normal women during the menstrual cycle Clin Endocrinol (Oxf) 36 1992 591 596
45. P. Ovesen, N. Vahl, and S. Fisker Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the preovulatory interval in normal women J Clin Endocrinol Metab 83 1998 1662 1667
46. G. van den Berg, J.D. Veldhuis, and M. Frolich An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women J Clin Endocrinol Metab 81 1996 2460 2466
47. J.D. Veldhuis, J.N. Roemmich, and A.D. Rogol Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females - a general clinical research center-based study J Clin Endocrinol Metab 85 2000 2385 2394
48. P. van Kesteren, P. Lips, and W. Deville The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals J Clin Endocrinol Metab 81 1996 2227 2232
49. S. Loche, A. Colao, and M. Cappa The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids J Clin Endocrinol Metab 82 1997 861 864
50. C.A. Lissett, and S.M. Shalet The impact of dose and route of estrogen administration on the somatotropic axis in normal women J Clin Endocrinol Metab 88 2003 4668 4672
51. M.L. Hartman, A.C. Faria, and M.L. Vance Temporal structure of in vivo growth hormone secretory events in man Am J Physiol 260 1991 E101 E110
52. Y. Shuto, T. Shibasaki, and A. Otagiri Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity J Clin Invest 109 2002 1429 1436
53. M.J. Low, V. Otero-Corchon, and A.F. Parlow Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth J Clin Invest 107 2001 1571 1580
54. S.M. Anderson, N. Shah, and W.S. Evans Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women J Clin Endocrinol Metab 86 2001 551 560
55. M.J. Bray, T.M. Vick, and N. Shah Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion J Clin Endocrinol Metab 86 2001 3143 3149
56. J.D. Veldhuis, W.S. Evans, and C.Y. Bowers Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu J Clin Endocrinol Metab 88 2003 5484 5489
57. S.M. Anderson, L. Wideman, and J.T. Patrie Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion J Clin Endocrinol Metab 86 2001 5904 5911
58. Y. Hataya, T. Akamizu, and K. Takaya A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans J Clin Endocrinol Metab 86 2001 4552
59. L. Di Vito, F. Broglio, and A. Benso The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans Clin Endocrinol (Oxf) 56 2002 643 648
60. J.D. Veldhuis, M. Bidlingmaier, and S.M. Anderson Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men J Clin Endocrinol Metab 86 2001 3304 3310
61. C. Camacho-Hubner, K.A. Woods, and F. Miraki-Moud Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion J Clin Endocrinol Metab 84 1999 1611 1616
62. N. Shah, W.S. Evans, and C.Y. Bowers Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: pulsatile, entropic, and nyctohemeral mechanisms J Clin Endocrinol Metab 84 1999 2140 2150
63. N. Shah, W.S. Evans, and C.Y. Bowers Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2 driven GH secretion in postmenopausal women J Clin Endocrinol Metab 85 2000 2649 2659
64. W.S. Evans, S.M. Anderson, and L.T. Hull Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1, 44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states J Clin Endocrinol Metab 86 2001 700 712
65. J.D. Veldhuis, W.S. Evans, and C.Y. Bowers Impact of estradiol supplementation on dual peptidyl drive of growth hormone secretion in postmenopausal women J Clin Endocrinol Metab 87 2002 859 866
66. J.D. Veldhuis, J. Patrie, and L. Wideman Contrasting negative-feedback control of endogenously driven and exercise-stimulated pulsatile growth hormone secretion in women and men J Clin Endocrinol Metab 89 2004 840 846
67. J.D. Veldhuis, S.M. Anderson, and J.T. Patrie Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive J Clin Endocrinol Metab 89 2004 121 127
68. J.D. Veldhuis, S.M. Anderson, and P. Kok Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women J Clin Endocrinol Metab 89 2004 1312 1318
69. C.Y. Bowers New insight into the control of growth hormone secretion D.L. Kleinberg D.R. Clemmons Central and peripheral mechanisms in pituitary disease 2002 BioScientifica Ltd Bristol (UK) 163 175
70. J.D. Veldhuis, J.T. Patrie, and K.T. Brill Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like GH secretion in healthy middle-aged and older adults J Clin Endocrinol Metab 89 12 2004 6291 6296
71. D. Erickson, D.M. Keenan, and K. Mielke Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp J Clin Endocrinol Metab 89 2004 4746 4754
72. S.M. Pincus, T. Mulligan, and A. Iranmanesh Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males Proc Natl Acad Sci U S A 93 1996 14100 14105
73. D.M. Keenan, J. Licinio, and J.D. Veldhuis A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis Proc Natl Acad Sci U S A 98 2001 4028 4033
74. D.M. Keenan, S.L. Alexander, and C.H.G. Irvine Reconstruction of in vivo time-evolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements in interglandular signaling Proc Natl Acad Sci U S A 101 2004 6740 6745
75. E.C. degli Uberti, M.R. Ambrosio, and S.G. Cella Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man J Clin Endocrinol Metab 82 1997 2885 2888
76. 2 in age-advanced men and women J Clin Endocrinol Metab 82 1997 1472 1479
77. J.D. Veldhuis, J.T. Patrie, and K. Frick Sustained GH and IGF-I responses to prolonged high-dose twice-daily GHRH stimulation in middle-aged and older men J Clin Endocrinol Metab 89 2004 6325 6330
78. A. Giustina, T. Scalvini, and C. Tassi Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone J Clin Endocrinol Metab 82 1997 1210 1219
79. J.P. Span, G.F. Pieters, and C.G. Sweep Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement J Clin Endocrinol Metab 85 2000 1121 1125
80. M.L. Hartman, S.M. Pincus, and M.L. Johnson Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release J Clin Invest 94 1994 1277 1288
81. J.D. Veldhuis, W.S. Evans, and A. Iranmanesh Short-term testosterone supplementation relieves growth hormone autonegative feedback in men J Clin Endocrinol Metab 89 2004 1285 1290
82. J.D. Veldhuis, S.M. Anderson, and A. Iranmanesh Testosterone blunts feedback inhibition of GH secretion by experimentally elevated IGF-I concentrations J Clin Endocrinol Metab 90 3 2005 1613 1617
83. E.E. Mueller, V. Locatelli, and D. Cocchi Neuroendocrine control of growth hormone secretion Physiol Rev 79 1999 511 607
84. C.Y. Bowers, R. Granda, and S. Mohan Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women J Clin Endocrinol Metab 89 2004 2290 2300
85. G. Aimaretti, G. Fanciulli, and S. Bellone Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency Eur J Endocrinol 145 2001 267 272
86. F. Nyberg Aging effects on growth hormone receptor binding in the brain Exp Gerontol 32 1997 521 528
87. S. Petersenn, A.C. Rasch, and M. Penshorn Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor Endocrinology 142 2001 2649 2659
88. G. Van den Berghe, R.C. Baxter, and F. Weekers A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness J Clin Endocrinol Metab 85 2000 183 192
89. G. Johannsson, G. Grimby, and K.S. Sunnerhagen Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults J Clin Endocrinol Metab 82 1997 2877 2884
90. R.C. Cuneo, F. Salomon, and G.F. Watts Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency Metabolism 42 1993 1519 1523
91. G. Johannsson, P. Marin, and L. Lonn Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure J Clin Endocrinol Metab 82 1997 727 734
92. G. Johannsson, and B.A. Bengtsson Growth hormone and the acquisition of bone mass Horm Res 48 Suppl 5 1997 72 77
93. B.A. Bengtsson Rethink about growth hormone therapy for critically ill patients Lancet 354 1999 1403 1404
94. L.R. Carvalho, M.E. de Faria, and M.G. Osorio Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy Clin Endocrinol (Oxf) 59 2003 788 792